“Appreciate the opportunity to be here today,” said keynote speaker Charlie Bachtell, co-founder & CEO of Cresco Labs Inc (OTCQX: CRLBF) at the September Benzinga Cannabis Capital Conference panel discussion, moderated by Debra Borchardt, executive editor at Green Market Report and John Pletz, a reporter at Crain Communications.
Amidst a room full of stakeholders eager to unravel the rapid strides and lurking challenges of the cannabis industry, Bachtell laid bare the strategic pivots and maneuvers that have kept Cresco Labs thriving in a tumultuous environment.
Want to know more about innovative business models, regulatory landscapes, and future growth prospects of the cannabis industry? Tune in to the Benzinga Cannabis Capital Conference in Chicago. For existing subscribers, you can get direct access through our research platform. For new users, you can get instant access here!
See Also: Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks
Cresco Labs' Performance, Strategy, & Industry Insights
The intimate dialogues between these renowned figures dabbled between Cresco Labs’ second-quarter performance and the legislative landscape surrounding the cannabis industry. Bachtell attributed the robust health of his company to a disciplined focus on core markets, products, brands, and team members, a strategy crafted out of the necessities spurred by unpredictable legislative and regulatory reforms.
“Shedding certain assets, choosing to keep others there are very few easy decisions in this industry,” Bachtell opened up, ...